Clinical Trial Update: Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections [Phase 3]

View source ↗

Summary

A Phase 3 study comparing eravacycline to meropenem in complicated intra-abdominal infections has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Appendicitis
• Complicated Intra-abdominal Infections

Drugs mentioned

• Eravacycline (eravacycline)
• Meropenem (Meropenem)

Snippet

Sponsor: Tetraphase Pharmaceuticals, Inc | Conditions: Complicated Intra-abdominal Infections, Complicated Appendicitis | Phase 3 | Status: COMPLETED | Results posted: 2019-02-18